$54,000
$1,097

The FDA is the Problem

BusinessWeek reports on funded companies with a focus on calorie restriction mimetics, and correctly identifies regulation as the biggest problem in the space: "A handful of biotech companies are developing drugs that produce the effects of such 'caloric restriction' in the body without depriving people of food. Anti-aging doctors would love to prescribe a medication that would extend their patients' life spans to 125 years -- extrapolating from mice. But companies would have no avenue for seeking Food & Drug Administration approval for such a treatment. 'It would be undoable,' says Stephen J. Hoffman, an investor in anti-aging biotech Sirtris Pharmaceuticals in Cambridge, Mass., who also sits on its board."

Link: http://www.businessweek.com/magazine/content/06_12/b3976007.htm

Comments

Post a comment; thoughtful, considered opinions are valued. Comments incorporating ad hominem attacks, advertising, and other forms of inappropriate behavior are likely to be deleted.

Note that there is a comment feed for those who like to keep up with conversations.